Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Sudeep Pharma Annual Report

Sudeep Pharma filed its FY 2025-26 Annual Report with BSE, declaring a ₹1.50 final dividend. It reports a market cap of ₹6,693 crore and entry into battery materials.

Source

BSE filing, NSE: SUDEEPPHRM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sudeep Pharma Ltd: key numbers

Share price
₹1,068.30
Market cap
₹12,066 Cr
Revenue (annual)
₹642.3 Cr
Net profit (annual)
₹172.9 Cr
P/E (TTM)
64.1×Sector 45.9×
Promoter holding
76.15%+0.00% QoQ
FII holding
2.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sudeep Pharma Ltd

All →
12:31 IST BSE
Capacity Expansion

Sudeep Pharma Capacity Expansion

Sudeep Pharma received FDA approval for its new 51,200 MT greenfield plant at Nandesari, Gujarat. Commercial operations are expected to commence in H2 FY27 following customer qualification.

manufacturing capacity
51200 MT

Other annual report announcements

All →